CELZ 株価推移チャート
CELZ 財務
Creative Medical Technology Holdings Inc
$0.95
-8.63%
$-0.08
終値： Sep 10, 16:00:00 GMT-4
$0.97
2.08%
$0.01
アフターマーケット：Sep 10, 20:00:00 GMT-4
戻る
Creative Medical Technology Holdings Inc (CELZ) 財務
主要データ
前終値
$1.04
始値
$1.05
当日レンジ
$0.9384 - $1.05
52週レンジ
$0.62 - $6.25
取引高
318.4K
平均取引高
6.6M
配当利回り
--
1株当たり利益(TTM)
-2.04
時価総額
$4.5M
CELZとは何ですか？
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company which focuses on immunology, urology, neurology and orthopedics using adult stem cell treatments and interrelated regenerative technologies for the treatment of multiple indications. The company is headquartered in Phoenix, Arizona and currently employs 4 full-time employees. The company went IPO on 2009-05-01. The firm conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.
